Conference Coverage
Conference Coverage
Eribulin fails to best capecitabine in advanced breast cancer
Major Finding: Eribulin was not significantly better than capecitabine in median overall survival (15.9 vs. 14.5 months, P = .056) or progression-...
Conference Coverage
Studies put kibosh on statins for breast cancer prevention
Conference Coverage
ONC-CHAT: What Did You Learn this Week that Will Change the Way You Work?
Conference Coverage
Ten Years of Adjuvant Tamoxifen Found Superior to Five
Major Finding: Women randomized to 10 years of adjuvant tamoxifen had a 25% reduction in recurrences and a 29% lower mortality due to breast...
Conference Coverage
Less Invasive Biopsy Used Less in Black Breast Cancer Patients
Major Finding: From 2002 to 2007, significantly fewer black women than white women with invasive breast cancer underwent a sentinel lymph node...
Conference Coverage
Experimental Drug Puts ER-Positive Breast Cancer on Hold
Major Finding: Compared with letrozole alone, letrozole plus PD 0332991 was associated with significantly better progression-free survival (26.1...
Conference Coverage
Breast Cancer: Molecular Profiling Doesn't Trump Standard Pathology
Conference Coverage
Dr. C. Kent Osborne Previews the San Antonio Breast Cancer Symposium
Conference Coverage
More Bevacizumab Trials to Report Outcomes in San Antonio
Conference Coverage
San Antonio Breast Cancer Symposium: More to Come on 2011 Practice Changers
Conference Coverage
Cardiac Toxicity Not Seen 25 Years after Breast Radiation
Major Finding: There were no significant differences in major cardiac function parameters between women treated with modified radical mastectomy...